TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/25/24 16:45 | 11/21/24 | LQR | Lqr House Inc. | NV | FdBev | Bev | Beverages | Lazar David E. | R1 | DO | P | S.m | 0 | 0.00 | 0 | -1,102 | -100 | 0 | D | ||||||||||||||
6/28/23 16:14 | 6/21/23 | TTNP | Titan Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazar David E. | C0 | DOT | CEO | S.a | -4,610 | 1.23 | 0 | -3,748 | -100 | 0 | M | ||||||||||||||
6/23/23 16:07 | 6/21/23 | TTNP | Titan Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazar David E. | C0 | DOT | CEO | S | -4,610 | 1.23 | 0 | -3,748 | -100 | 0 | M | ||||||||||||||
1/26/23 13:05 | 1/24/23 | TTNP | Titan Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazar David E. | C0 | DOT | CEO | P.m | 56 | 0.9789 | 0 | 58 | 2 | 3,748 | D | ||||||||||||||
7/8/22 18:00 | 7/6/22 | TTNP | Titan Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Lazar David E. | C0 | T | P.m | 1,923 | 0.8638 | 0 | 2,226 | 152 | 3,690 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |